JNJ241220C160000
- 0.01
- 0.000.00%
Johnson & Johnson Newsroom
Dividend Roundup: Johnson & Johnson, JPMorgan, Oracle, Mastercard, and More
Johnson & Johnson To Go Ex-Dividend On February 18th, 2025 With 1.24 USD Dividend Per Share
U.S. Companies With Potential Pension Risk Transfer Restructuring Opportunities
5 Low-Leverage Stocks Worth Adding to Your Portfolio in 2025
Smart Money Is Betting Big In JNJ Options
Johnson & Johnson Declares $1.24 Quarterly Dividend; 3.4% Yield
Press Release: Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
Express News | Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
Johnson & Johnson (JNJ.US) has applied for the market launch of its innovative compound drug "Mexitentan Tadalafil Tablets" in China for the treatment of pulmonary arterial hypertension.
The CDE website shows that Johnson & Johnson (JNJ.US) has submitted an application for the innovative compound drug "Maqitengtan Tadalafil Tablets" to be marketed domestically for the treatment of pulmonary arterial hypertension (PAH).
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
These Are the Best and Worst Stocks This Year
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
Investors in Johnson & Johnson (NYSE:JNJ) Have Unfortunately Lost 8.8% Over the Last Three Years
Is Johnson & Johnson (JNJ) the Best Pharma Dividend Stock to Buy In 2024?
Dow's Nearly 225-Point Drop Led By Losses In Nike, Boeing Stocks
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
J&J Trading Near 52-Week Low: Should You Sell the Stock?
Johnson & Johnson (JNJ.US) has introduced Kaken's preclinical STAT6 inhibitor.
Kaken will receive a prepayment of 30 million dollars from Johnson & Johnson (JNJ.US), as well as subsequent payments of up to 1.2175 billion dollars based on development progress and sales milestones.